Literature DB >> 32364926

PAP use in mild cognitive impairment to delay progression to dementia.

Michelangelo Maestri1, Claudio Liguori2, Enrica Bonanni1, Biancamaria Guarnieri3,4.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32364926      PMCID： PMC7446078          DOI： 10.5664/jcsm.8536

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN： 1550-9389            Impact factor:   4.062


× No keyword cloud information.
  6 in total

1.  The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Use of positive airway pressure in mild cognitive impairment to delay progression to dementia.

Authors:  Virginia Skiba; Marina Novikova; Aarushi Suneja; Beth McLellan; Lonni Schultz
Journal:  J Clin Sleep Med       Date:  2020-06-15       Impact factor: 4.062

3.  Obstructive Sleep Apnea is Associated With Early but Possibly Modifiable Alzheimer's Disease Biomarkers Changes.

Authors:  Claudio Liguori; Nicola Biagio Mercuri; Francesca Izzi; Andrea Romigi; Alberto Cordella; Giuseppe Sancesario; Fabio Placidi
Journal:  Sleep       Date:  2017-05-01       Impact factor: 5.849

4.  CPAP Adherence May Slow 1-Year Cognitive Decline in Older Adults with Mild Cognitive Impairment and Apnea.

Authors:  Kathy C Richards; Nalaka Gooneratne; Barry Dicicco; Alexandra Hanlon; Stephen Moelter; Fannie Onen; Yanyan Wang; Amy Sawyer; Terri Weaver; Alicia Lozano; Patricia Carter; Jerry Johnson
Journal:  J Am Geriatr Soc       Date:  2019-02-06       Impact factor: 5.562

5.  Treatment of sleep apnoea syndrome decreases cognitive decline in patients with Alzheimer's disease.

Authors:  Anne-Cécile Troussière; Christelle Monaca Charley; Julia Salleron; Florence Richard; Xavier Delbeuck; Philippe Derambure; Florence Pasquier; Stéphanie Bombois
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-05-14       Impact factor: 10.154

6.  Obstructive sleep apnea, cognition and Alzheimer's disease: A systematic review integrating three decades of multidisciplinary research.

Authors:  Omonigho M Bubu; Andreia G Andrade; Ogie Q Umasabor-Bubu; Megan M Hogan; Arlener D Turner; Mony J de Leon; Gbenga Ogedegbe; Indu Ayappa; Girardin Jean-Louis G; Melinda L Jackson; Andrew W Varga; Ricardo S Osorio
Journal:  Sleep Med Rev       Date:  2019-12-12       Impact factor: 11.609
  6 in total
  1 in total

1.  18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment.

Authors:  Mariana Fernandes; Luisa Mari; Agostino Chiaravalloti; Barbara Paoli; Marzia Nuccetelli; Francesca Izzi; Maria Pia Giambrone; Riccardo Camedda; Sergio Bernardini; Orazio Schillaci; Nicola Biagio Mercuri; Fabio Placidi; Claudio Liguori
Journal:  J Neurol       Date:  2022-05-24       Impact factor: 6.682
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.